Clinical Trial Update: A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing SHR-1210 in combination with capecitabine plus oxaliplatin or apatinib for advanced gastric cancer has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Cancer

Drugs mentioned

• Apatinib (apatinib)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• SHR-1210 (camrelizumab)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Gastric Cancer, GastroEsophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-01-11